nach oben

Erschienen in:

01.05.2020 | Case report

Ipilimumab/nivolumab/pembrolizumab

Secondary adrenal insufficiency and various other toxicities: 11 case reports

Einloggen, um Zugang zu erhalten

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

…

Yano S, et al. Human leucocyte antigen DR15, a possible predictive marker for immune checkpoint inhibitor-induced secondary adrenal insufficiency. European Journal of Cancer 130: 198-203, May 2020. Available from: URL: http://doi.org/10.1016/j.ejca.2020.02.049

Titel: Ipilimumab/nivolumab/pembrolizumab
Secondary adrenal insufficiency and various other toxicities: 11 case reports
Publikationsdatum: 01.05.2020
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2020
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-020-78339-5